TipRanks
Anthem Biosciences Limited (IN:ANTHEM)
:ANTHEM
India Market
ANTHEM
Anthem Biosciences Limited
RESEARCH TOOLSreports
Want to see IN:ANTHEM full AI Analyst Report?

Anthem Biosciences Limited (ANTHEM) Stock Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

ANTHEM Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Anthem
Biosciences Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ANTHEM Stock 12 Month Forecast

There Are No Analyst Ratings for IN:ANTHEM In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ANTHEM Financial Forecast

ANTHEM Earnings Forecast

Next quarter’s earnings estimate for ANTHEM is ₹3.50 with a range of ₹3.50 to ₹3.50. The previous quarter’s EPS was ₹2.10. ANTHEM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year ANTHEM has Performed in-line its overall industry.
Next quarter’s earnings estimate for ANTHEM is ₹3.50 with a range of ₹3.50 to ₹3.50. The previous quarter’s EPS was ₹2.10. ANTHEM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year ANTHEM has Performed in-line its overall industry.

ANTHEM Sales Forecast

Next quarter’s sales forecast for ANTHEM is ₹6.27B with a range of ₹5.93B to ₹6.77B. The previous quarter’s sales results were ₹4.18B. ANTHEM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year ANTHEM has Performed in-line its overall industry.
Next quarter’s sales forecast for ANTHEM is ₹6.27B with a range of ₹5.93B to ₹6.77B. The previous quarter’s sales results were ₹4.18B. ANTHEM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year ANTHEM has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on IN:ANTHEM
Bansi Desai
J.P. Morgan
J.P. Morgan
₹900
Buy
-2.51%
Downside
Reiterated
07/23/26
Anthem Biosciences Limited (ANTHEM) Receives a Buy from J.P. Morgan
Prabhudas Lilladher Analyst forecast on IN:ANTHEM
Unknown Analyst
Prabhudas Lilladher
Not Ranked
Prabhudas Lilladher
₹755
Buy
-18.21%
Downside
Initiated
03/30/26
We initiate coverage on ANTHEM with 'BUY' rating and TP of INR755/share.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on IN:ANTHEM
Bansi Desai
J.P. Morgan
J.P. Morgan
₹900
Buy
-2.51%
Downside
Reiterated
07/23/26
Anthem Biosciences Limited (ANTHEM) Receives a Buy from J.P. Morgan
Prabhudas Lilladher Analyst forecast on IN:ANTHEM
Unknown Analyst
Prabhudas Lilladher
Not Ranked
Prabhudas Lilladher
₹755
Buy
-18.21%
Downside
Initiated
03/30/26
We initiate coverage on ANTHEM with 'BUY' rating and TP of INR755/share.
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Anthem Biosciences Limited

3 Months
Bansi DesaiJ.P. Morgan
Success Rate
2/2 ratings generated profit
100%
Average Return
+10.20%
Copying Bansi Desai's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.20% per trade.
1 Year
Bansi DesaiJ.P. Morgan
Success Rate
2/2 ratings generated profit
100%
Average Return
+8.25%
Copying Bansi Desai's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +8.25% per trade.
2 Years
Bansi DesaiJ.P. Morgan
Success Rate
2/2 ratings generated profit
100%
Average Return
+8.25%
Copying Bansi Desai's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +8.25% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ANTHEM Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
1
2
1
1
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
2
1
1
0
In the current month, ANTHEM has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ANTHEM average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

ANTHEM Stock Forecast FAQ

What is IN:ANTHEM’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:ANTHEM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:ANTHEM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Anthem Biosciences Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Anthem Biosciences Limited’s share price target?
      Currently, no data Available
      What do analysts say about Anthem Biosciences Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Anthem Biosciences Limited?
      To buy shares of IN:ANTHEM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.